3 results
Approved WMORecruiting
To compare PFS of patients with progressive, advanced, kinase inhibitor naïve, RET-mutant MTC treated with selpercatinib versus cabozantinib or vandetanib.
Approved WMORecruiting
To confirm the performance and long term safety of MisagoPeripheral Self-Expanding Stent System for the treatment ofoccluded or stenotic Superficial Femoral or Popliteal arteries in thedaily practice
Approved WMORecruiting
Primary objective:To demonstrate superiority of Qutenza over low-dose capsaicin control in change from baseline to Week 12 in the 24-hr average pain intensity in subjects with PSNP.Secondary objective:• To demonstrate superiority of Qutenza over low…